| Helvepharm AG - Dexamethason Zentiva 5 mg, Injektionslösung |
| 41074 | | 03 | | Dexamethason Zentiva 5 mg | | Injektionslösung | | H02AB02 | | Dexamethason | | 23.07.1997 | | |
|
| Composition |
| dexamethasoni natrii phosphas 5 mg corresp. dexamethasonum 3.8 mg, dinatrii edetas, natrii citras dihydricus, natrii hydroxidum q.s. ad pH, glycerolum, E 223 1 mg, alcohol benzylicus 10.5 mg, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 1.1 mg. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Déxamethasone Sodium Phosphate | 5 mg correspond Dexamethasone 3.8 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Déxamethasone Sodium Phosphate | 5 mg |
| | | | Agents auxilliaires |
|---|
| Dinatrii Edetas | | Natrii Citras Dihydricus | | Sodium Hydroxide |
| |
|
|
